logo
Plus   Neg
Share
Email

Eli Lilly Promotes Ilya Yuffa To SVP & President Of Lilly Bio-Medicines

Eli Lilly and Company (LLY) announced the appointment of Ilya Yuffa, currently vice president of U.S. Diabetes, to the new role of senior vice president and president of Lilly Bio-Medicines. Patrik Jonsson, senior vice president and president of Lilly Bio-Medicines, will become senior vice president, president of Lilly USA, and Chief Customer Officer. The appointments are effective October 1, 2020.

David Ricks, Lilly chairman and CEO stated: "Now is the time to name a dedicated executive to lead Lilly USA and our global customer-focused functions during this time of exciting growth."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT